0001213900-23-096082.txt : 20231215 0001213900-23-096082.hdr.sgml : 20231215 20231215160825 ACCESSION NUMBER: 0001213900-23-096082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KING THOMAS BRAXTON CENTRAL INDEX KEY: 0001279309 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 231490365 MAIL ADDRESS: STREET 1: 91 JAMES AVENUE CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml X0508 4 2023-12-13 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001279309 KING THOMAS BRAXTON 91 JAMES AVENUE ATHERTON CA 94027 1 0 0 0 0 Stock Options (Right to Buy) 0.35 2023-12-13 4 A 0 132442 0 A 2024-12-13 2033-12-13 Common Stock 132442 132442 D The options vest and first become exercisable in 36 equal monthly installments, with the first installment vesting on December 13, 2024 and the remaining installments on the 13th of the month for the next 35 months. /s/ Thomas B. King 2023-12-15